Vozoris Nicholas T, Wang Xuesong, Fischer Hadas D, Gershon Andrea S, Bell Chaim M, Gill Sudeep S, O'Donnell Denis E, Austin Peter C, Stephenson Anne L, Rochon Paula A
Division of Respirology, Department of Medicine, St Michael's Hospital, Toronto, Ontario, Canada.
Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
Br J Clin Pharmacol. 2016 Jan;81(1):161-70. doi: 10.1111/bcp.12762. Epub 2015 Oct 2.
The purpose of the present study was to describe the scope, pattern and patient characteristics associated with incident opioid use among older adults with chronic obstructive pulmonary disease (COPD).
This was a retrospective population-based cohort study using Ontario, Canada, healthcare administrative data. Study participants were individuals aged 66 years and older with physician-diagnosed COPD, identified using a validated algorithm, who were not receiving palliative care. We examined the incidence of oral opioid receipt between 1 April 2003 and 31 March 2012, as well as several patterns of incident opioid drug use.
Among 107,109 community-dwelling and 16,207 long-term care resident older adults with COPD, 72,962 (68.1%) and 8811 (54.4%), respectively, received an incident opioid drug during the observation period. Among long-term care residents, multiple opioid dispensings (8.8%), dispensings for >30 days' duration (up to 19.8%), second dispensings (35-43%) and early refills (24.2%) were observed. Incident opioid dispensing was also observed to occur during COPD exacerbations (6.9% among all long-term care residents; 18.1% among long-term care residents with frequent exacerbations). These same patterns of incident opioid use occurred among community-dwelling individuals, but with relatively lower frequencies.
New opioid use was high among older adults with COPD. Potential safety concerns are raised by the degree and pattern of new opioid use, but further studies are needed to evaluate if adverse events are associated with opioid drug use in this older and respiratory-vulnerable population.
本研究旨在描述慢性阻塞性肺疾病(COPD)老年患者中阿片类药物使用情况的范围、模式及患者特征。
这是一项基于人群的回顾性队列研究,使用加拿大安大略省的医疗管理数据。研究参与者为66岁及以上经医生诊断患有COPD的个体,通过经过验证的算法识别,且未接受姑息治疗。我们调查了2003年4月1日至2012年3月31日期间口服阿片类药物的接受情况,以及阿片类药物使用的几种模式。
在107,109名社区居住的COPD老年患者和16,207名长期护理机构居住的老年患者中,分别有72,962名(68.1%)和8811名(54.4%)在观察期内接受了阿片类药物。在长期护理机构居住的患者中,观察到多次阿片类药物配药(8.8%)、配药持续时间超过30天(高达19.8%)、第二次配药(35 - 43%)和提前续方(24.2%)。在COPD加重期间也观察到了阿片类药物的配药情况(所有长期护理机构居住患者中为6.9%;频繁加重的长期护理机构居住患者中为18.1%)。在社区居住个体中也出现了相同的阿片类药物使用模式,但频率相对较低。
COPD老年患者中新发阿片类药物使用情况较为普遍。新发阿片类药物使用的程度和模式引发了潜在的安全担忧,但需要进一步研究来评估在这个年龄较大且呼吸系统脆弱的人群中不良事件是否与阿片类药物使用有关。